If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

Share Price is delayed by 15 minutes
Get Live Data
1,068.00    14.50 (1.38%)
Bid:
1,066.00
Ask:
1,067.00
Spread: 1.00 (0.094%)
Market Cap: £3.43b
PSN Live PriceLast checked at - London Stock Exchange

Intraday Persimmon Share Chart

Board Change

29 Apr 2020 07:01

RNS Number : 2284L
Persimmon PLC
29 April 2020
 

29 April 2020

 

Persimmon plc

 

Appointment of Annemarie Durbin as Independent Non-Executive Director

 

Persimmon Plc is pleased to announce the appointment of Annemarie Durbin to the Board as an Independent Non-Executive Director with effect from 1 July 2020. Annemarie will also join the Company's Remuneration Committee as Chair, and the Nomination Committee, on the same date.

Annemarie has 30 years broad-based, retail, commercial, corporate and institutional banking experience across Asia, Africa & the Middle East and is an experienced coach and mentor. She spent 20 years at Standard Chartered, the FTSE 100 international bank, in a variety of executive roles across the UK and Asia, culminating in membership of the Group Executive Committee. She has subsequently become a highly Experienced Board Chair, Independent Non-Executive Director and Remuneration Committee Chair.

Annemarie is currently a non-executive director and Remuneration Committee Chair of W H Smith PLC and Santander UK plc, and is non-executive Board Chair of Merryck & Co a leading coaching and mentoring group. She was previously a non-executive director of Ladbrokes Coral Plc.

Roger Devlin, Chairman of Persimmon, said: "Annemarie is a highly experienced international business executive, with a strong background in corporate governance and human resources. Her experience and knowledge will be invaluable to Persimmon as we continue to implement our programme of business improvement. I am pleased to welcome Annemarie to the board."

As noted in the 2019 Annual Report, Marion Sears, who was due to retire as a Non-Executive Director of the Company, and Chair of the Remuneration Committee, at the conclusion of the Annual General Meeting on 29 April 2020, will now remain on the Board until 30 June 2020 to allow time for Annemarie to take up her post.

 

No further information is required to be disclosed pursuant to Listing Rule 9.6.13.

 

For further information, please contact:

Citigate Dewe Rogerson

Simon Rigby / Kevin Smith / Jos Bieneman

Tel: +44 (0)20 7638 9571

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAQVLFLBZLXBBQ
Date   Source Headline
1st Dec 20234:45 pmRNSTotal Voting Rights
17th Nov 202310:25 amRNSHolding(s) in Company
8th Nov 20237:00 amRNSAppointment of Chief Financial Officer
7th Nov 20237:00 amRNSQ3 Trading Statement
3rd Nov 20231:15 pmRNSHolding(s) in Company
1st Sep 20231:15 pmRNSTotal Voting Rights
10th Aug 20237:04 amRNSHalf Year Results
27th Jul 202310:13 amRNSDirectorate Change
10th Jul 20239:27 amRNSDirector Declaration
3rd Jul 20232:46 pmRNSTotal Voting Rights
1st Jun 20234:38 pmRNSTR-1: Notification of major holdings
1st Jun 20231:07 pmRNSBlock listing Interim Review
1st Jun 202311:06 amRNSTotal Voting Rights
3rd May 20235:00 pmRNSHolding(s) in Company
3rd May 20234:12 pmRNSDirector/PDMR Shareholding
2nd May 202311:13 amRNSTotal Voting Rights
26th Apr 20234:32 pmRNSResult of AGM
26th Apr 20237:00 amRNSQ1 Trading Statement
3rd Apr 20234:01 pmRNSDirector/PDMR Shareholding
3rd Apr 20233:05 pmRNSTotal Voting Rights
27th Mar 20233:44 pmRNSDirector/PDMR Shareholding
22nd Mar 20233:00 pmRNSAnnual Report 2022 and Notice of AGM 2023
13th Mar 20231:57 pmRNSDirectorate Change
13th Mar 202312:19 pmRNSUK Government Self Remediation Contract Signed
7th Mar 20235:33 pmRNSHolding(s) in Company
7th Mar 20237:04 amRNSDirector Declaration
6th Mar 20235:02 pmRNSHolding(s) in Company
1st Mar 20237:00 amRNSFull Year Results
12th Jan 20237:00 amRNSTrading Statement
1st Dec 20225:30 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Dec 20225:25 pmRNSVoting Rights and Capital
8th Nov 20227:00 amRNSTrading Statement
1st Nov 20221:00 pmRNSTotal Voting Rights
1st Nov 20229:24 amRNSHolding(s) in Company
10th Oct 20222:24 pmRNSDirector/PDMR Shareholding
5th Oct 202210:26 amRNSHolding(s) in Company
4th Oct 20223:07 pmRNSDirector/PDMR Shareholding
3rd Oct 20222:12 pmRNSTotal Voting Rights
22nd Sep 20223:54 pmRNSDirector/PDMR Shareholding
17th Aug 20227:00 amRNSHalf Year Results
1st Aug 20222:30 pmRNSTotal Voting Rights
20th Jul 20224:14 pmRNSHolding(s) in Company
13th Jul 20224:40 pmRNSHolding(s) in Company
12th Jul 20222:20 pmRNSDirector/PDMR Shareholding
7th Jul 20227:00 amRNSTrading Update
4th Jul 20222:44 pmRNSHolding(s) in Company
1st Jul 20222:28 pmRNSTotal Voting Rights
27th Jun 20225:15 pmRNSHolding(s) in Company
23rd Jun 20224:46 pmRNSNew Chief Financial Officer Start Date
6th Jun 20225:28 pmRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.